查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
用藥依從性設備市場 - 2018-2028年全球行業規模、佔有率、趨勢、機會和預測F 按類型、按藥物、按地區和競爭情況分類
市場調查報告書
商品編碼
1309874

用藥依從性設備市場 - 2018-2028年全球行業規模、佔有率、趨勢、機會和預測F 按類型、按藥物、按地區和競爭情況分類

Medication Adherence Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented Type, By Medication, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在預測期內，全球用藥依從性設備市場預計將出現令人矚目的成長。這主要得益於越來越多的計劃和活動旨在教育人們堅持用藥的重要性。此外，老齡化人口的不斷增加、醫療保健支出的不斷成長以及藥品使用量的不斷上升，預計也將在預測期內為市場創造巨大的成長機會。同樣，心血管疾病發病率的成長也是多年來推動市場成長的主要因素。此外，心臟病患者不遵醫囑用藥的高發率也導致了預測期內對遵醫設備的需求。廣泛的研發（R&D）支出和不斷擴大的醫療成本也會促進市場的成長。根據美國疾病控制和預防中心（CDC）的數據，2019 年美國10 個主要死因中有7 個是慢性病。在各種慢性病中，心臟病和癌症共佔2019 年美國死亡總人數的近46%。

心血管疾病發病率不斷上升

慢性疾病通常需要使用大劑量藥物進行長期治療干涉，任何中斷服藥的行為都可能造成致命後果，因此需要嚴格遵守用藥規定，這將在預測期內進一步推動市場成長。心血管疾病是全球主要慢性疾病之一。冠心病症候群、腦血管疾病、風濕性心臟病和其他疾病是最常見的心血管疾病。據世界衛生組織（WHO）統計，全球每年死於心血管疾病的人數佔總死亡人數的32%，即1790 萬人。此外，由於心臟結構和功能的逐漸退化，越來越多的老年人群很容易出現心臟缺陷，這在很大程度上加重了心血管疾病的負擔；因此，在預測期內，先進的遵醫囑用藥設備的採用率會越來越高。由於遺傳因素和環境因素，氧化應激性心臟病正在迅速增加。慢性疾病的改善需要臨床干涉，而臨床干涉則是通過提高以患者為中心的用藥依從性計劃的參與度來實現的，這推動了全球用藥依從性設備市場的擴大。

對高級用藥依從性的需求不斷成長

在預測期內，對高級用藥依從性系統日益成長的需求將推動全球用藥依從性設備市場的成長。在全球範圍內，醫療保健生態系統因先進診斷和治療市場參與者的存在而變得支離破碎。醫療保健專業人員和患者之間的協調不斷加強，提高了醫療保健的品質和成本，因為這導致了醫療保健資訊（如病史、患者人口統計、賬單、診斷和管理數據）的碎片化，而這反過來又有望在未來幾年內促進市場的成長。

堅持用藥的意識不斷增強

由於發起了拯救病人的計劃，人們對堅持用藥的認知不斷提高，這是推動堅持用藥設備市場在預測期內成長的一個主要因素。堅持用藥計劃有助於提高患者的依從性。用藥依從性設備還能幫助藥劑師識別未按時服藥的患者。此外，各種政府和非政府組織也在讚助各種活動和會議，對患者和護理人員進行用藥依從性教育，從而推動了全球用藥依從性設備市場的多年成長。 2021 年8 月，西奈山醫療系統開始使用一款首創的行動應用程式，以加快和加強對心臟病發作患者的護理。該應用程式由西奈山的介入心臟病專家、急診科醫生和護理團隊共同開發，可改善醫生、護士和臨床指揮中心之間的溝通，使患者能得到更快速的護理，從而改善預後。

最新進展

  • 2018 年11 月， AdhereTech 公司宣布獲得Argentum 集團的投資。該公司表示，有了這筆新融資，它將增加藥房和製藥合作夥伴關係，並擴展到更多的醫療保健垂直領域。
  • 2021 年9 月： Curant Health 與美國人保公司（Humana Inc.這項新穎的試點計劃旨在改善患者的用藥依從性，幫助他們過上更健康的生活，並最終幫助降低醫療成本。

可用的客製化服務

TechSci Research 可根據給定的市場數據，按照公司的具體需求提供客製化服務。本報告提供以下客製化選項：

公司資訊

  • 其他市場參與者（最多五家）的詳細分析和概況。

目錄

第1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 研究年份
    • 主要市場細分

第2 章：研究方法

  • 研究目的
  • 基準方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第3 章：執行摘要

  • 市場概述
  • 主要市場細分概述
  • 主要市場參與者概述
  • 主要地區/國家概述
  • 市場驅動因素、挑戰和趨勢概述

第4章：客戶之聲

第5章：全球用藥依從性設備市場展望

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按地區
    • 按公司（2022 年）
  • 產品地圖

第6 章: 北美用藥依從性設備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按國家
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7 章：歐洲用藥依從性設備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8 章: 亞太地區用藥依從性設備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按國家
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9 章: 南美洲用藥依從性設備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按國家
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10 章: 中東和非洲用藥依從性設備市場前景

  • 市場規模與預測
    • 按價值
  • 市場佔有率與預測
    • 按類型（以硬體為中心和以軟體為中心）
    • 按藥物（心血管、中樞神經系統、糖尿病、腫瘤、胃腸道、肌肉骨骼、其他）
    • 按國家
  • 中東和非洲：國家分析
    • 南非用藥依從性設備
    • 沙烏地阿拉伯用藥依從性設備
    • 阿拉伯聯合大公國用藥依從性設備

第11 章：市場動態

  • 驅動因素
  • 挑戰

第12 章：市場趨勢與發展

第13 章：全球用藥依從性設備市場：SWOT分析

第14章：波特五力分析法

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15 章：競爭格局

  • 業務概述
  • 產品供應
  • 近期發展
  • 財務狀況（報告）
  • 主要人員
  • SWOT 分析
    • CareFusion.
    • Proteus Digital Health.
    • DrFirst.com,Inc.
    • AdhereTech Inc.
    • MedMinder.
    • Caredose.
    • Fruitech Ltd.
    • PHC Holdings Corporation.
    • MedAdvisor International Pty Ltd.
    • McKesson Corporation.

第16 章：戰略建議

簡介目錄
Product Code: 14710

Global Medication Adherence Devices market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing programs and initiatives organized to educate people about the significance of medical adherence. Also, the growing aging population, increasing development of healthcare expenditure, and rising usage of pharmaceuticals are expected to create significant growth opportunities for the market during the forecast period. Similarly, the growing prevalence of cardiovascular diseases is the major factor fuelling the growth of the market over the years. Additionally, the high frequency non-adherence to medication among cardiac patients has resulted in demand for medical adherence devices in the forecast period. The extensive research and development (R&D) expenditures, and expanding healthcare costs can boost the growth of the market. According to the US Centers for Disease Control and Prevention (CDC), 7 out of the 10 major causes of death in 2019 in the US were chronic illnesses. Among the various chronic diseases, heart diseases and cancer together accounted for nearly 46% of all deaths in the US in 2019.

Growing Prevalence of Cardiovascular Diseases

Most often, chronic diseases require a long therapeutic intervention by using high-dose drugs and any interruption in the medication intake can create fatal consequences which need strict medication adherence and will further boost the growth of the market during the forecast period. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among the most commonly observed cardiovascular diseases. According to the World Health Organization (WHO), 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. Furthermore, the increasing geriatric population is susceptible to heart defects due to progressive deterioration in the structure and function of the heart, which largely contributes to the high burden of CVDs; thereby triggering the increased adoption of advanced medication adherence devices during the forecast period. Due to genetic factors, environmental factors, the oxidative stress heart diseases are increasing rapidly. The improvement of chronic diseases necessitates clinical intervention, which is accomplished by increasing the participation of patient-centric medication adherence programs, fuelling the expansion of the global medication adherence devices market.

Growing Demand for Advanced Medication Adherence

The growing demand for advanced medication adherence systems is driving the global medication adherence devices market growth in the forecast period. The healthcare ecosystem is fragmented across the globe by the presence of market players for the advanced diagnosis and treatment. The growing coordination among healthcare professionals and patients has enhanced the quality of care and its cost, as it leads to the fragmentation of healthcare information such as medical history, patient demographics, billing, diagnosis and administrative data, and this in turn is expected to boost the growth of the market over the years.

Growing Awareness about Medication Adherence

The growing awareness of medication adherence, on account of the patient-saving programs being initiated, is a major factor fuelling the growth of the medication adherence devices market in the forecast period. Medication adherence programs help in improving patient compliance. Medical adherence devices also aid pharmacists in identifying patients missing out on the timely intake of medicines. Besides, various government and non-government organizations are sponsoring events and conferences to educate patients and caregivers about medication adherence thereby driving the global medication adherence devices market growth over the years. In August 2021, Mount Sinai Health System started using a first-of-its-kind mobile application to expedite and enhance care for patients with heart attacks. The app, developed by Mount Sinai's interventional cardiologists, emergency department physicians, and the nursing team, improves communication among doctors, nurses, and the clinical command center so that patients can get more rapid care to improve outcomes.

Market Segmentation

Global Medication Adherence Devices Market can be segmented by type, medication, region and competitional landscape. Based on the type, the market can be divided into hardware centric and software centric. Based on medication, the market can be segmented into cardiovascular, central nervous system, diabetes, oncology, gastrointestinal, musculoskeletal, and others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominates the global medication adherence devices market on account of the increasing prevalence of cardiovascular diseases in the country.

Market Players

CareFusion., Proteus Digital Health., DrFirst.com, Inc., AdhereTech Inc., MedMinder., Caredose. Fruitech Ltd., PHC Holdings Corporation, MedAdvisor International Pty Ltd., McKesson Corporation. are some of the leading players operating in the Global Medication Adherence Devices Market.

Recent Developments

  • In November 2018, AdhereTech Inc., announced receiving investment from Argentum Group. The company stated that with this new financing it would be increasing its pharmacy and pharmaceutical partnerships and expand into more healthcare verticals.
  • September 2021: Curant Health and Humana Inc. teamed up to help in achieving better health outcomes for Humana members suffering from Chronic Obstructive Pulmonary Disease (COPD) and Chronic Heart Failure (CHF). The novel pilot program, aimed at refining medication adherence to help patients lead healthier lives and eventually help lessen health care costs, offers inclusive support for members suffering from complex health conditions and prescription medication needs.

Report Scope

In this report, Global Medication Adherence Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Devices Market, By Type:

  • Hardware Centric
  • Software Centric

Medication Adherence Devices Market, By Medication:

  • Cardiovascular
  • Central Nervous System
  • Diabetes
  • Oncology
  • Gastrointestinal
  • Musculoskeletal
  • Others

Medication Adherence Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medication Adherence Devices Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Hardware Centric v/s Software Centric)
    • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Product Map

6. North America Medication Adherence Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Hardware Centric v/s Software Centric)
    • 6.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medication Adherence Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Medication
    • 6.3.2. Canada Medication Adherence Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Medication
    • 6.3.3. Mexico Medication Adherence Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Hardware Centric v/s Software Centric)
    • 7.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Medication Adherence Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Medication
    • 7.3.2. Germany Medication Adherence Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Medication
    • 7.3.3. United Kingdom Medication Adherence Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Medication
    • 7.3.4. Italy Medication Adherence Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Medication
    • 7.3.5. Spain Medication Adherence Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Medication

8. Asia-Pacific Medication Adherence Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Hardware Centric v/s Software Centric)
    • 8.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Medication Adherence Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Medication
    • 8.3.2. India Medication Adherence Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Medication
    • 8.3.3. Japan Medication Adherence Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Medication
    • 8.3.4. South Korea Medication Adherence Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Medication
    • 8.3.5. Australia Medication Adherence Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Medication

9. South America Medication Adherence Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Hardware Centric v/s Software Centric)
    • 9.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Medication Adherence Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Medication
    • 9.3.2. Argentina Medication Adherence Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Medication
    • 9.3.3. Colombia Medication Adherence Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Medication

10. Middle East and Africa Medication Adherence Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Hardware Centric v/s Software Centric)
    • 10.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Medication Adherence Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Medication
    • 10.3.2. Saudi Arabia Medication Adherence Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Medication
    • 10.3.3. UAE Medication Adherence Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Medication

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Global Medication Adherence Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 CareFusion.
    • 15.6.2 Proteus Digital Health.
    • 15.6.3 DrFirst.com,Inc.
    • 15.6.4 AdhereTech Inc.
    • 15.6.5 MedMinder.
    • 15.6.6 Caredose.
    • 15.6.7 Fruitech Ltd.
    • 15.6.8 PHC Holdings Corporation.
    • 15.6.9 MedAdvisor International Pty Ltd.
    • 15.6.10 McKesson Corporation.

16. Strategic Recommendations